Literature DB >> 8739908

Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: a three year follow-up study.

P Szulc1, M C Chapuy, P J Meunier, P D Delmas.   

Abstract

We have previously shown that elderly women with an increased serum undercarboxylated osteocalcin (ucOC) level have an increased risk of sustaining a hip fracture as compared to those with normal serum ucOC. We reassessed our findings on a larger number of hip fractures that occurred over 3 years in 183 institutionalized women (aged 70-97 years) belonging to a large prospective clinical trial. Total OC, carboxylated OC, ucOC, and alkaline phosphatase were significantly higher at baseline in those who sustained a hip fracture during the follow-up. The age-adjusted odds ratio for hip fracture was three times higher in women with increased ucOC at baseline (odds ratio = 3.1, 99.9% C.I. = 1.7-6.0, p < 0.001). In the logistic regression, ucOC was still predictive of the hip fracture when age and parathyroid hormone concentration were included into the model (odds ratio = 2.6, 95% C.I. = 1.05-6.4). These data confirm that ucOC is a marker of the increased risk of hip fracture in elderly institutionalized women. Serum ucOC may reflect some nutritional deficiency associated with increased bone fragility.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8739908     DOI: 10.1016/8756-3282(96)00037-3

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  37 in total

Review 1.  An overview of osteocalcin progress.

Authors:  Jinqiao Li; Hongyu Zhang; Chao Yang; Yinghui Li; Zhongquan Dai
Journal:  J Bone Miner Metab       Date:  2016-01-08       Impact factor: 2.626

2.  Vitamin D sufficiency is associated with low incidence of limb and vertebral fractures in community-dwelling elderly Japanese women: the Muramatsu Study.

Authors:  K Nakamura; T Saito; M Oyama; R Oshiki; R Kobayashi; T Nishiwaki; M Nashimoto; Y Tsuchiya
Journal:  Osteoporos Int       Date:  2010-03-24       Impact factor: 4.507

3.  Association of serum undercarboxylated osteocalcin with serum estradiol in pre-, peri- and early post-menopausal women.

Authors:  T Yasui; H Uemura; J Tomita; Y Miyatani; M Yamada; M Miura; M Irahara
Journal:  J Endocrinol Invest       Date:  2006-11       Impact factor: 4.256

4.  Effect of high dietary sodium on bone turnover markers and urinary calcium excretion in Korean postmenopausal women with low bone mass.

Authors:  S M Park; J Y Joung; Y Y Cho; S Y Sohn; K Y Hur; J H Kim; S W Kim; J H Chung; M K Lee; Y-K Min
Journal:  Eur J Clin Nutr       Date:  2015-02-04       Impact factor: 4.016

5.  Vitamin K and metabolic bone disease.

Authors:  C Vermeer; M H Knapen; L J Schurgers
Journal:  J Clin Pathol       Date:  1998-06       Impact factor: 3.411

6.  Meta-analysis of genome-wide association studies for circulating phylloquinone concentrations.

Authors:  Hassan S Dashti; M Kyla Shea; Caren E Smith; Toshiko Tanaka; Adela Hruby; Kris Richardson; Thomas J Wang; Mike A Nalls; Xiuqing Guo; Yongmei Liu; Jie Yao; Dalin Li; W Craig Johnson; Emelia J Benjamin; Stephen B Kritchevsky; David S Siscovick; José M Ordovás; Sarah L Booth
Journal:  Am J Clin Nutr       Date:  2014-10-08       Impact factor: 7.045

7.  No effect of vitamin K1 intake on bone mineral density and fracture risk in perimenopausal women.

Authors:  L Rejnmark; P Vestergaard; P Charles; A P Hermann; C Brot; P Eiken; L Mosekilde
Journal:  Osteoporos Int       Date:  2006-05-09       Impact factor: 4.507

Review 8.  Efficacy of menatetrenone (vitamin K2) against non-vertebral and hip fractures in patients with neurological diseases: meta-analysis of three randomized, controlled trials.

Authors:  Jun Iwamoto; Hideo Matsumoto; Tsuyoshi Takeda
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

9.  Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women.

Authors:  M H J Knapen; L J Schurgers; C Vermeer
Journal:  Osteoporos Int       Date:  2007-02-08       Impact factor: 4.507

Review 10.  Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club.

Authors:  P Bergmann; J-J Body; S Boonen; Y Boutsen; J-P Devogelaer; S Goemaere; J-M Kaufman; J-Y Reginster; V Gangji
Journal:  Int J Clin Pract       Date:  2009-01       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.